Immunopathogenesis of hepatitis C virus infection

被引:74
作者
Freeman, AJ
Marinos, G
Ffrench, RA
Lloyd, AR
机构
[1] Prince Wales Hosp, Gastrointestinal & Liver Unit, Randwick, NSW 2031, Australia
[2] Sydney Childrens Hosp, Westfield Res Labs, Randwick, NSW, Australia
[3] Univ New S Wales, Sch Pathol, Inflammat Res Unit, Kensington, NSW 2033, Australia
关键词
CD8; chronic hepatitis; cytotoxic T lymphocytes; Flaviviridae; hepatitis C virus; immunity; liver; viral hepatitis; viral persistence;
D O I
10.1046/j.1440-1711.2001.01036.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 [细胞生物学]; 090102 [作物遗传育种];
摘要
Hepatitis C virus, a recently identified member of the family Flaviviridae, is an important cause of chronic viral hepatitis and cirrhosis. There are similarities in the nature of the immune response to this pathogen with immunity in other flavivirus and hepatotropic virus infections, such as hepatitis B. However, the high rate of viral persistence after primary hepatitis C infection, and the observation that neutralizing antibodies are not protective, would suggest that there are a number of important differences between hepatitis C, other flaviviruses, and hepatitis B. The phenomenon of quasispecies evolution and other viral factors have been proposed to contribute to immune evasion by hepatitis C virus. In the face of established persistent infection, virus-specific cytotoxic T lymphocytes may exert some control over viral replication. However, these same effectors may also be responsible for the progressive liver damage characteristic of chronic hepatitis C infection. The nature of protective immunity, including the role of innate immune responses early after hepatitis C exposure, remains to be defined.
引用
收藏
页码:515 / 536
页数:22
相关论文
共 361 条
[1]
Immune responses throughout hepatitis C virus (HCV) infection: HCV from the immune system point of view [J].
Abrignani, S .
SPRINGER SEMINARS IN IMMUNOPATHOLOGY, 1997, 19 (01) :47-55
[2]
Natural recovery from acute hepatitis C virus infection by agammaglobulinemic twin children [J].
Adams, G ;
Kuntz, S ;
Rabalais, G ;
Bratcher, D ;
Tamburro, CH ;
Kotwal, GJ .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1997, 16 (05) :533-534
[3]
Adinolfi LE, 1998, AM J GASTROENTEROL, V93, P2162, DOI 10.1111/j.1572-0241.1998.00613.x
[4]
Hepatitis C virus and other Flaviviridae viruses enter cells via low density lipoprotein receptor [J].
Agnello, V ;
Abel, G ;
Elfahal, M ;
Knight, GB ;
Zhang, QX .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (22) :12766-12771
[5]
Detection of widespread hepatocyte infection in chronic hepatitis C [J].
Agnello, V ;
Abel, G ;
Knight, GB ;
Muchmore, E .
HEPATOLOGY, 1998, 28 (02) :573-584
[6]
Genes of the major histocompatibility complex class II influence the outcome of hepatitis C virus infection [J].
Alric, L ;
Fort, M ;
Izopet, J ;
Vinel, JP ;
Charlet, JP ;
Selves, J ;
Puel, J ;
Pascal, JP ;
Duffaut, M ;
Abbal, M .
GASTROENTEROLOGY, 1997, 113 (05) :1675-1681
[7]
DETECTION OF ANTIBODY TO HEPATITIS-C VIRUS IN PROSPECTIVELY FOLLOWED TRANSFUSION RECIPIENTS WITH ACUTE AND CHRONIC NON-A-HEPATITIS, NON-B-HEPATITIS [J].
ALTER, HJ ;
PURCELL, RH ;
SHIH, JW ;
MELPOLDER, JC ;
HOUGHTON, M ;
CHOO, QL ;
KUO, G .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (22) :1494-1500
[8]
THE NATURAL-HISTORY OF COMMUNITY-ACQUIRED HEPATITIS-C IN THE UNITED-STATES [J].
ALTER, MJ ;
MARGOLIS, HS ;
KRAWCZYNSKI, K ;
JUDSON, FN ;
MARES, A ;
ALEXANDER, WJ ;
HU, PY ;
MILLER, JK ;
GERBER, MA ;
SAMPLINER, RE ;
MEEKS, EL ;
BEACH, MJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (27) :1899-1905
[9]
Epidemiology of hepatitis C [J].
Alter, MJ .
HEPATOLOGY, 1997, 26 (03) :S62-S65
[10]
The prevalence of hepatitis C virus infection in the United States, 1988 through 1994 [J].
Alter, MJ ;
Kruszon-Moran, D ;
Nainan, OV ;
McQuillan, GM ;
Gao, FX ;
Moyer, LA ;
Kaslow, RA ;
Margolis, HS .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (08) :556-562